rs10752609

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002249.6(KCNN3):​c.1029+3437C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.583 in 152,082 control chromosomes in the GnomAD database, including 27,535 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 27535 hom., cov: 32)

Consequence

KCNN3
NM_002249.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.180

Publications

6 publications found
Variant links:
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
KCNN3 Gene-Disease associations (from GenCC):
  • Zimmermann-Laband syndrome 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.795 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002249.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNN3
NM_002249.6
MANE Select
c.1029+3437C>T
intron
N/ANP_002240.3
KCNN3
NM_001204087.2
c.1029+3437C>T
intron
N/ANP_001191016.1
KCNN3
NM_001365837.1
c.90+3437C>T
intron
N/ANP_001352766.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNN3
ENST00000271915.9
TSL:1 MANE Select
c.1029+3437C>T
intron
N/AENSP00000271915.3
KCNN3
ENST00000361147.8
TSL:1
c.114+3437C>T
intron
N/AENSP00000354764.4
KCNN3
ENST00000358505.2
TSL:1
c.90+3437C>T
intron
N/AENSP00000351295.2

Frequencies

GnomAD3 genomes
AF:
0.583
AC:
88536
AN:
151964
Hom.:
27493
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.783
Gnomad AMI
AF:
0.305
Gnomad AMR
AF:
0.629
Gnomad ASJ
AF:
0.433
Gnomad EAS
AF:
0.816
Gnomad SAS
AF:
0.435
Gnomad FIN
AF:
0.484
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.472
Gnomad OTH
AF:
0.527
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.583
AC:
88640
AN:
152082
Hom.:
27535
Cov.:
32
AF XY:
0.581
AC XY:
43183
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.784
AC:
32519
AN:
41500
American (AMR)
AF:
0.630
AC:
9627
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
1503
AN:
3470
East Asian (EAS)
AF:
0.816
AC:
4218
AN:
5170
South Asian (SAS)
AF:
0.434
AC:
2091
AN:
4822
European-Finnish (FIN)
AF:
0.484
AC:
5106
AN:
10558
Middle Eastern (MID)
AF:
0.357
AC:
105
AN:
294
European-Non Finnish (NFE)
AF:
0.472
AC:
32084
AN:
67970
Other (OTH)
AF:
0.527
AC:
1110
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1783
3566
5348
7131
8914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.495
Hom.:
36693
Bravo
AF:
0.608
Asia WGS
AF:
0.650
AC:
2256
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
2.7
DANN
Benign
0.40
PhyloP100
0.18
Mutation Taster
=16/84
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10752609; hg19: chr1-154791128; API